NEW YORK, July 22, 2026, 11:16 a.m. EDT
Zhongchao Inc. NASDAQ:ZCMD jumped 456% to $8.18 by 11:02 a.m. EDT Wednesday. Nasdaq’s regular session remained open.
Volume had reached 65.79 million shares by 10:53 a.m. That equaled roughly 57 times the 1.15 million-share public float.
The turnover was the main investor signal. The latest company release shown on reviewed market feeds was dated June 25. That suggests market structure, not fresh operating data, drove the spike.
Trading was repeatedly interrupted. Three Limit Up-Limit Down pauses hit ZCMD before 10:30 a.m. The Nasdaq Composite was down 0.32% at 11:02 a.m.
Preliminary calculations using time-stamped intraday data show the dislocation.
| Metric | ZCMD | Reference point | Difference |
|---|---|---|---|
| Price change | +456.46% | Nasdaq Composite −0.32% | +456.78 percentage points |
| Share volume | 65.79 million | Public float 1.15 million | 57.2 times |
| Share volume | 65.79 million | 65-day average 1.83 million | 36.0 times |
Short positioning could have added fuel. MarketWatch showed 378,500 shares short on June 30, or 32.95% of float. The figure does not prove covering drove Wednesday’s move.
The float was compressed by three consolidations this year. Ratios of 1-for-8, 1-for-31 and 1-for-3 took effect March 2, June 8 and June 29. For shares held throughout, the ratios multiply to 1-for-744.
Zhongchao said the final action aimed “to maintain its listing” on Nasdaq. It left about 1.15 million Class A shares outstanding. PR Newswire
The shrinking base followed a May capital raise. Zhongchao priced 9.26 million units at 54 cents, targeting $5 million in gross proceeds. Each unit carried a share, or pre-funded warrant, plus a six-month warrant.
Those warrants create a large supply risk. At the stated floor, the prospectus said one warrant could yield up to nine shares. Zhongchao said zero-price exercises would bring no cash and cause substantial dilution.
The operating record offers little near-term anchor. Audited 2025 revenue fell 28% to $11.37 million. Consolidated net loss widened to $5.81 million from $0.27 million. Cash ended the year at $8.10 million.
Zhongchao is a Cayman holding company. Its operating businesses serve oncology and other major-disease patients. The company consolidates them through contractual VIE arrangements. It says it owns no equity in the VIE or its subsidiaries.
Risks: Low-float rallies can reverse quickly. Warrant exercises may expand supply, while renewed listing pressure could trigger more corporate action. The VIE arrangement adds regulatory and enforcement risk.
For investors, the next hard evidence will be a fresh filing. Share count, warrant exercises and cash use matter more than Wednesday’s tape.
